Noah Goodman sold $570K of Kymera Therapeutics (KYMR)

Executed Jun 25, disclosed Jun 25, the same day.

Value, as filed

$570K

5,000 sh across 2 lots

Executed

Jun 25

the trade date, as filed

Disclosed

Jun 25

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Noah Goodman Chief Business Officer profile →

Noah Goodman (Chief Business Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $898K of KYMR (10,264 sh across 4 lots, as filed), executed Apr 9.

The name

KYMR

Kymera Therapeutics, Inc. KYMR · Healthcare · 59 filings in 24 months ticker →

Healthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Noah Goodman in KYMR

KYMRSALE Kymera Therapeutics, Inc. $387K
3,389 sh × $114.29
Exec Jul 1
Filed Jul 2 · 6:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $248K
2,500 sh × $99.00
Exec Jun 22
Filed Jun 22 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $121K
1,347 sh × $90.00
Exec Apr 14
Filed Apr 16 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $898K
10,264 sh across 4 lots
Exec Apr 9
Filed Apr 10 · 5:30 PM ET